Insider Stock Trading History of Kelly Michael P


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kelly Michael P since year 2005. The trader's CIK number is 1497881. At the time of this reporting, Kelly Michael P is the President, Global Markets of Haemonetics Corp . (stock ticker symbol HAE). See this page for all insider trading activities at Haemonetics Corp .


Stock purchases, sales, and option exercises reported by insider Kelly Michael P since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-11-11 HAE Haemonetics Corp Option Ex 58,600 32.40 1,898,815
2013-11-12 HAE Haemonetics Corp Option Ex 2,800 27.48 76,958
2013-11-11 HAE Haemonetics Corp Sale 58,600 39.70 2,326,478
2013-11-12 HAE Haemonetics Corp Sale 2,800 39.66 111,050
2013-10-14 HAE Haemonetics Corp Sale 1,400 40.41 56,568
2013-10-14 HAE Haemonetics Corp Option Ex 1,400 27.48 38,479
2013-09-13 HAE Haemonetics Corp Option Ex 1,400 27.48 38,479
2013-09-13 HAE Haemonetics Corp Sale 1,400 40.36 56,506
2013-07-12 HAE Haemonetics Corp Option Ex 1,400 27.48 38,479
2013-07-12 HAE Haemonetics Corp Sale 1,400 44.10 61,740
2013-06-14 HAE Haemonetics Corp Option Ex 1,400 27.48 38,479
2013-06-14 HAE Haemonetics Corp Sale 1,400 42.17 59,033
2013-05-14 HAE Haemonetics Corp Option Ex 1,400 27.48 38,479
2013-05-14 HAE Haemonetics Corp Sale 1,400 39.66 55,525
2013-04-12 HAE Haemonetics Corp Option Ex 1,400 27.48 38,479
2013-04-12 HAE Haemonetics Corp Sale 1,400 40.92 57,294
2013-03-14 HAE Haemonetics Corp Sale 1,400 41.14 57,589
2013-03-14 HAE Haemonetics Corp Option Ex 1,400 27.48 38,479
2013-02-14 HAE Haemonetics Corp Option Ex 1,400 27.48 38,479
2013-02-14 HAE Haemonetics Corp Sale 1,400 41.71 58,394
2013-01-14 HAE Haemonetics Corp Sale 1,400 42.29 59,211
2013-01-14 HAE Haemonetics Corp Option Ex 1,400 27.48 38,479

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelly Michael P (President, Global Markets of Haemonetics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.